These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19901690)

  • 1. Concerns regarding the methodology of the study entitled "Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?".
    Suzuki H; Kagawa H; Iwata K
    J Trauma; 2009 Nov; 67(5):1133; author reply 1133-4. PubMed ID: 19901690
    [No Abstract]   [Full Text] [Related]  

  • 2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia?
    Pea F; Viale P
    J Trauma; 2009 Oct; 67(4):893-4; author reply 894-5. PubMed ID: 19820604
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
    Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C
    Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-escalation therapy in ventilator-associated pneumonia.
    Niederman MS
    Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
    Magnotti LJ; Schroeppel TJ; Clement LP; Swanson JM; Bee TK; Maish GO; Minard G; Zarzaur BL; Fischer PE; Fabian TC; Croce MA
    J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy for ventilator-associated pneumonia: de-escalation in the real world.
    Depuydt P; Blot S
    Crit Care Med; 2007 Feb; 35(2):632-3. PubMed ID: 17251705
    [No Abstract]   [Full Text] [Related]  

  • 9. A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.
    Khan RA; Aziz Z
    Int J Clin Pharm; 2017 Aug; 39(4):906-912. PubMed ID: 28643112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia.
    Housman ST; Kuti JL; Nicolau DP
    Clin Chest Med; 2011 Sep; 32(3):439-50. PubMed ID: 21867814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?
    Niederman MS; Soulountsi V
    Clin Chest Med; 2011 Sep; 32(3):517-34. PubMed ID: 21867820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline use in critically ill older patients: case reports and critical analysis.
    Curcio D; Fernández F; Duret F
    J Am Geriatr Soc; 2007 Feb; 55(2):312-3. PubMed ID: 17302676
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia.
    Benko R; Matuz M; Doro P; Peto Z; Molnar A; Hajdu E; Nagy E; Gardi J; Soos G
    Int J Antimicrob Agents; 2007 Aug; 30(2):162-8. PubMed ID: 17570646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which is the right antibiotic treatment for ventilator-associated pneumonia?
    Corona A
    Crit Care Med; 2007 Jul; 35(7):1808; author reply 1808-9. PubMed ID: 17581392
    [No Abstract]   [Full Text] [Related]  

  • 15. How can earlier antibiotic efficacy be provided for ventilator-associated pneumonia without promoting bacterial resistance? Is initial monotherapy or a combination of antibiotics the right answer?
    Papazian L
    Crit Care Med; 2008 Mar; 36(3):994-5. PubMed ID: 18431296
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia.
    Morris AC; Kefala K; Simpson AJ; Wilkinson TS; Everingham K; Kerslake D; Raby S; Laurenson IF; Swann DG; Walsh TS
    Thorax; 2009 Jun; 64(6):516-22. PubMed ID: 19213771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic selection is crucial for optimal empiric monotherapy of ventilator-associated pneumonia.
    Cunha BA
    Crit Care Med; 2007 Aug; 35(8):1992-4. PubMed ID: 17667252
    [No Abstract]   [Full Text] [Related]  

  • 18. Aerosolized antibiotics in critically ill ventilated patients.
    Palmer LB
    Curr Opin Crit Care; 2009 Oct; 15(5):413-8. PubMed ID: 19657273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines.
    Kuti JL; Shore E; Palter M; Nicolau DP
    Semin Respir Crit Care Med; 2009 Feb; 30(1):102-15. PubMed ID: 19199192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can bacteriological upper airway samples obtained at intensive care unit admission guide empiric antibiotherapy for ventilator-associated pneumonia?
    Pirracchio R; Mateo J; Raskine L; Rigon MR; Lukaszewicz AC; Mebazaa A; Hammitouche Y; Sanson-Le Pors MJ; Payen D
    Crit Care Med; 2009 Sep; 37(9):2559-63. PubMed ID: 19623054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.